# ComKardia, Inc. — Form D

ComKardia, Inc. of NEWTON, MA, a company, filed a Form D exempt-offering notice with the SEC on 2022-09-28. The offering totals $3.1M, of which $250K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2022-09-28
- Form: D
- Accession: 0001932266-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.1M
- Amount sold: $250K
- Remaining: $2.9M
- Investors: 1
- Date of first sale: 2022-09-13
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-460092

## Issuer

- Name: ComKardia, Inc.
- CIK: 0001932266
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 43 PARKER STREET, NEWTON, MA, 02459
- Phone: 857-234-2646

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Ioannis Chatzizisis | Director | Newton, MA |
| Maria Kyparissopoulou | Director | Newton, MA |
| Maria Kyparissopoulou | Executive Officer | Newton, MA |

## More

- [CIK 1932266 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1932266&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001932266-22-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.